Averin Capital
Venture capitalActively deployingNew York · Seed–Growth · 3 people tracked
Investment thesis
Averin Capital focuses on transformative healthcare and life sciences innovations across the disease detection, treatment delivery, and personalized medicine spectrum. The firm leverages its team's operational expertise from founding and scaling over 30 companies to provide hands-on support and strategic guidance. The investment thesis emphasizes meaningful medical breakthroughs and significant societal transformations in human health, with a partnership approach that respects founder autonomy while offering deep domain knowledge and industry networks.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from the firm's website
What they invest in
from 3 of 10 portfolio companiesDigital Health ×3Healthtech ×3Medical Devices ×2AI & Machine Learning ×1Biotech ×1Consumer ×1
HQs:United States×1
Investments · 10 tracked
founders shown can be your intro pathA product designed to be better for patients, easier and more cost-effective for practitioners while addressing market needs.
Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment. The company partners with licensed dentists and orthodontists to provide high-quality orthodontic care.
ConsumerDigital HealthHealthtechMedical Devices
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Riley Ennis(Co-Founder and Chief Product Officer)
Combines biosensors and GLP-1 receptor agonists to revolutionize diabetes care through real-time monitoring, personalized insights, and better blood sugar control with weight management.
A clinical-stage artificial intelligence company using Large Medicine Models to optimize drug development, especially in late-stage clinical trials.
A pioneering liquid biopsy company pursuing FDA approvals for cancer diagnostics with leading sensitivity and specificity.
Pine Park Health operates a team-based primary care model that provides medical care, preventive screening, and health coordination services for patients. The clinical team includes board-certified nurse practitioners and physician associates who work with a medical director and care coordinators to deliver personalized care plans.
Digital HealthHealthtechSan Francisco, US
Payam Parvinchiha(Chief Medical Officer)
Frequently asked questions
- What stage does Averin Capital invest at?
- Averin Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Averin Capital focus on?
- Averin Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Averin Capital located?
- Averin Capital is headquartered in New York, US.
From the blog
visit blog ↗Averin Capital has written on structural barriers to AI adoption in biotech: talent loss driven by job design rather than compensation, liability gaps blocking clinical AI deployment, and state-level regulatory changes creating alternative pathways for experimental medicine commercialization." AI summary
Images
Similar investors
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.